Analyst Price Targets — CLPBY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 25, 2025 1:20 pm | — | Bernstein | $14.45 | $11.07 | TheFly | Coloplast price target raised to $14.45 from $13.50 at Bernstein |
Latest News for CLPBY
Investors with an interest in Medical - Instruments stocks have likely encountered both Coloplast A/S Sponsored ADR (CLPBY) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?
Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) and OPKO Health (NASDAQ: OPK - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Institutional and Insider Ownership 64.6% of OPKO Health
Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.
Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY - Get Free Report)'s share price gapped down prior to trading on Friday. The stock had previously closed at $8.38, but opened at $7.83. Coloplast A/S shares last traded at $7.92, with a volume of 21,573 shares traded. Analyst Ratings Changes Separately, Sanford C. Bernstein raised Coloplast A/S to
Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CLPBY.
Senate Trading
No Senate trades found for CLPBY.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.